CNBX Pharmaceuticals Inc. (CNBX) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$0

Net Income/Loss (FY2025)

-$314.0K

Total Assets (FY2025)

$18.4K

Total Equity (FY2025)

-$2.5M

Cash Flows from Operating Activities (FY2025)

-$171.3K

Source: CNBX Pharmaceuticals Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.